Portfolio company
Multiomic Health
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform for discovering precision medicines and biomarkers for patients with metabolic syndrome-related chronic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Preview Health
This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.
MetaSight
MetaSight Diagnostics develops multi-omics liquid biopsy tests for the early detection of chronic and acute diseases for healthcare providers and patients.
CardiaTec Biosciences
This company develops an artificial intelligence platform to identify cardiovascular drug targets for pharmaceutical providers using large-scale multi-omics data.
Phitech
The company develops an artificial intelligence platform for multi-omics diagnostic decision support, serving hospitals, diagnostic laboratories and biopharmaceutical organisations.
Holifya
The company provides an AI-supported digital clinic platform and personalised pharmacologic treatments for patients managing obesity and metabolic syndrome.
OMNIA-X
This company develops a health intelligence platform that integrates medical, biometric and behavioural data to provide personalised psychophysical health analysis for individuals.
RxDiet
This company develops an AI platform providing medically tailored meal plans and grocery delivery for patients with chronic conditions like diabetes and hypertension.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
